TCS 3,493.95 -18.40 (-0.52%) HDFCBANK 1,712.35 +6.55 (0.38%) 
HINDUNILVR 2,166.70 -9.15 (-0.42%) INFY 1,593.00 +13.75 (0.87%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,640.25 +7.40 (0.45%) KOTAKBANK 1,993.65 +8.85 (0.45%) ICICIBANK 1,273.45 +23.20 (1.86%) ITC 408.70 -3.15 (-0.76%) BAJFINANCE 8,580.00 +160.75 (1.91%) MARUTI 11,524.80 +16.15 (0.14%) HCLTECH 1,531.40 -3.15 (-0.21%) SBIN 725.95 -1.80 (-0.25%) NESTLEIND 2,169.25 -22.60 (-1.03%) ASIANPAINT 2,207.60 -23.35 (-1.05%) WIPRO 260.90 -3.05 (-1.16%) DMART 3,816.55 +19.00 (0.50%) AXISBANK 1,033.60 +23.45 (2.32%) LT 3,184.75 -3.65 (-0.11%) HDFCLIFE 630.35 +8.05 (1.29%) SUNPHARMA 1,702.70 +18.85 (1.12%) ULTRACEMCO 10,486.20 +37.70 (0.36%) ONGC 228.20 +2.75 (1.22%) BAJAJFINSV 1,868.25 +61.30 (3.39%) BPCL 259.50 -4.75 (-1.80%) POWERGRID 267.15 -0.45 (-0.17%) TITAN 3,016.65 +7.40 (0.25%) BRITANNIA 4,647.95 -80.10 (-1.69%) NTPC 332.75 +1.05 (0.32%) Download Unicorn Signals App
By EquityPandit
On Thursday, Glenmark Pharma said that it has got USFDA’s final approval for manufacturing and marketing Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the American market.
The company said in a BSE filing that “Glenmark Pharmaceuticals Inc has been granted final approval by the US Food and Drug Administration (US FDA) for Potassium Chloride extended release capsules USP, 10mEq, of Actavis Laboratories FL, Inc.”
